Catalyst Wire Dossier Catalyst Wire Dossier

GSK3335065

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK3335065, covering 2019-09-20 to 2019-09-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Investigation of GSK3335065 Intravenous (IV) Infusion in Healthy Adults [Phase 1]

See pricing